Dövizler / BSX
BSX: Boston Scientific Corporation
103.65
USD
1.45
(1.38%)
BSX fiyatı bugün -1.38% değişti. Gün boyunca enstrüman, Düşük fiyatı olarak 102.27 ve Yüksek fiyatı olarak 105.40 aralığında işlem gördü.
Boston Scientific Corporation hareketlerini izleyin. Gerçek zamanlı fiyatlar, piyasa değişikliklerine hızlı bir şekilde tepki vermenize yardımcı olacaktır. Farklı zaman dilimleri arasında geçiş yaparak döviz kurunun trendlerini ve hareketlerini dakika, saat, gün, hafta ve ay bazında takip edebilirsiniz. Piyasa değişikliklerini tahmin etmek ve bilinçli alım-satım kararları vermek için bu bilgileri kullanın.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
BSX haberleri
- Investor's Business Daily Stock Market Week Ahead: Tesla, Alphabet, GE Vernova And Defense Stocks
- Investor's Business Daily Dow Jones Futures: Tesla, Google Step Up With Earnings Due; AI Stock Breaks Out As Nvidia, AMD Run
- Zacks Molina to Report Q2 Earnings: Healthy Revenues, Weak Pulse on Earnings
- Zacks Here's Why You Should Hold Accuray Stock in Your Portfolio for Now
- Zacks Exploring Analyst Estimates for Boston Scientific (BSX) Q2 Earnings, Beyond Revenue and EPS
- Zacks Abbott Stock Falls in Pre-Market Despite Q2 Earnings and Sales Beat
- Investing Schrodinger stock maintains Buy rating at Citi on Ajax collaboration
- Zacks ZBH Stock Set to Benefit From New Monogram Technologies Buyout Deal
- Zacks ANGO Stock Down Despite Q4 Earnings Beat, Gross Margin Declines
- Zacks Reasons to Add DENTSPLY SIRONA Stock to Your Portfolio Now
- Zacks PAHC or BSX: Which Is the Better Value Stock Right Now?
- Zacks Boston Scientific (BSX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Zacks GMED Unveils Next-Gen Oscillating System DuraPro: Stock to Gain?
- Zacks Will Robust MedSurg Performance Fuel Boston Scientific's Q2 Earnings?
- Zacks Why Boston Scientific (BSX) Outpaced the Stock Market Today
- Zacks Elevance to Report Q2 Earnings: Will Rising Costs Pressure Profits?
- Investor's Business Daily Hinge Health Stock Earns Relative Strength Rating Upgrade
- Investing Medtronic stock gains as CMS proposes renal denervation coverage
- Investing William Blair reiterates Market Perform rating on Medtronic stock after CMS proposal
- Investing JPMorgan maintains Neutral rating on Medtronic stock amid renal denervation coverage win
- Investing Medtronic stock rises as CMS proposes favorable coverage for RDN therapy
- Investing Medtronic stock jumps as CMS proposes coverage for renal denervation
- Investing Edwards Lifesciences stock rating maintained at Hold by Canaccord Genuity
- Investor's Business Daily Semler Scientific Stock Gets Relative Strength Rating Upgrade
Günlük aralık
102.27
105.40
Yıllık aralık
71.88
107.53
- Önceki kapanış
- 104.64
- Açılış
- 105.10
- Satış
- 103.65
- Alış
- 103.95
- Düşük
- 102.27
- Yüksek
- 105.40
- Hacim
- 17.690 K
- Günlük değişim
- -1.38%
- Aylık değişim
- -3.28%
- 6 aylık değişim
- 2.22%
- Yıllık değişim
- 39.54%
20 Temmuz, Pazar